Cargando…

Reversible Parkinsonism and Multiple Cerebral Infarctions after Pulmonary Endarterectomy in a Patient with Antiphospholipid Syndrome

Antiphospholipid syndrome (APS) is a cause of chronic thromboembolic pulmonary hypertension (CTEPH) and it is associated with an increased risk of postoperative neurological complications. We experienced a case of reversible parkinsonism after pulmonary endarterectomy (PEA) and subsequent multiple c...

Descripción completa

Detalles Bibliográficos
Autores principales: Okano, Mitsumasa, Nakayama, Kazuhiko, Tamada, Naoki, Shinkura, Yuto, Yanaka, Ken-ichi, Onishi, Hiroyuki, Tanaka, Hidekazu, Shinke, Toshiro, Tanaka, Hiroshi, Okita, Yutaka, Emoto, Noriaki, Hirata, Ken-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096019/
https://www.ncbi.nlm.nih.gov/pubmed/29321405
http://dx.doi.org/10.2169/internalmedicine.9880-17
Descripción
Sumario:Antiphospholipid syndrome (APS) is a cause of chronic thromboembolic pulmonary hypertension (CTEPH) and it is associated with an increased risk of postoperative neurological complications. We experienced a case of reversible parkinsonism after pulmonary endarterectomy (PEA) and subsequent multiple cerebral infarctions under standard anticoagulation therapy in a patient with CTEPH associated with APS. Strict management using a combination of antiplatelet and anticoagulation therapy should be considered in patients with a high titer of triple antiphospholipid antibodies in the perioperative period. We should be aware of the high risk of postoperative neurologic manifestations in patients with APS.